Skip to main content
. 2019 Jul 26;98(30):e16598. doi: 10.1097/MD.0000000000016598

Figure 3.

Figure 3

The survival difference among four therapeutic modalities in patients with gastric cancer. (A) The modalities with or without IPHP in the 1-, 2-survival of patients with gastric cancer. ∗ denoted there was a statistically difference among the groups, P value <.05. (B) 1 year survival curve of patients treated with four modalities. (C) 2-year survival curve of patients treated with four modalities. IPHP = intraperitoneal hyperthermic perfusion. Blue line = operation alone, green line = operation + chemotherapy, yellow line = operation + IPHP, purple line = operation + IPHP + chemotherapy.